Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 Agonists
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
The Kokomo woman was pre-diabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...
The Danish Prime Minister Mette Frederiksen will meet with French President Emmanuel Macron, with German Chancellor Olaf Scholz, and NATO Secretary General Mark Rutte on Tuesday, starting today in a ...
Hosted on MSN19h
Novo Nordisk shares surge on results of new obesity drug trialNovo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
was $540 now $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback